Non-Communicable Pediatric Diseases Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, IR Iran. , hadisorkhi@yahoo.com
Abstract: (5871 Views)
Tacrolimus is a main drug for induction and maintenance immunosuppression for patients with kidney transplants in many centers. One of important side effect of drug is post-transplant diabetes mellitus. Of course, diabetes ketoacidosis (DKA) is rare. In this report, a 12-year-old girl with DKA was presented after 45 days of kidney transplantation.
Sorkhi H, Alijanpour M, Sadr Moharrerpour S. Tacrolimus and diabetic ketoacidosis after kidney transplantation in a 15-year-old girl (Case Report). CJP 2016; 2 (2) :171-174 URL: http://caspianjp.ir/article-1-59-en.html